Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.
- +32 3 689 85 38
- Technology Lane 82, 9052 Ghent Belgium
- info@gulliverbiomed.com
Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.
We foster single domain antibody (sdAb) research in general and bring these powerful tools to private enterprises and the scientific community at large.
NANOBODY® antibodies, VHHs or single domain antibodies afford many opportunities in (bio)medicine, bio-engineering, diagnostics, personalized medicine (i.e. CAR-T), and way beyond. They reduce inherent problems of reproducibility experienced with conventional antibodies because their cDNA and protein sequences are always available, by default. In addition, NANOBODY® antibodies are 10 times smaller compared to regular antibodies (IgGs), greatly facilitating bio-engineering and custom adaptation.
We provide these sophisticated biologicals for your (bio)medical, biochemical, biophysical, pharmaceutical, cell biological research needs, custom tailored. Peruse our catalogue or contact us to develop your own personal set of VHHs and stay on top of research. As you get accustomed to their flexibility, versatility and broad application range in vitro and in vivo, these unique antibodies will inspire you to envisage new applications and boost your work.
NANOBODY® compounds are registered trademarks of Ablynx N.V.